COPENHAGEN (MedPage Today) -- Long-term treatment with serial onabotulinum toxin A (Botox) of urinary incontinence among multiple sclerosis (MS) patients appeared to be safe and effective, researchers reported here.

Repeat Botox OK for Urinary Incontinence in MS Patients

(MedPage Today) -- The risk of celiac disease was higher in children who were introduced to gluten after 6 months of age and in those breastfed longer than 12 months, a prospective birth cohort study found.

Timing Key When Introducing Gluten to Baby (CME/CE)

From left: Michael F. Rotondo, MD, FACS, Chair of the ACS COT; winning presenters Drs. Hampton, Ali, Long, Turnbull, and Zargaran; and Dr. Coimbra.

Bradley Gelfand, assistant professor in the Department of Ophthalmology and Visual Sciences at the University of Kentucky College of Medicine, has received a $100,000 one-year grant from the International Retinal Research Foundation (IRRF) for his study “Iron-induced Alu RNA stability and toxicity in geographic atrophy.” Gelfand's lab is investigating the integration of two disease causing phenomena -- iron overload and Alu RNA buildup - into one overarching model. "The disease we are studying is geographic atrophy, which is the advanced stage of ‘dry’ age-related macular degeneration," Ge

First-generation college students face a myriad of unique obstacles; as the first people in their families to attend college, their experiences are inherently different from those of other students.  As such, the UK Office of First Generation Initiatives serves to support these students by addressing needs, skill sets and support mechanisms specific to first-gen students. 

The University of Kentucky Center for Clinical and Translational Science (CCTS) Pilot Funding Program announces recipients of its most recent round of pilot funding in the Collaborative Category.
To address institution-wide needs for structural analysis and quantitation of a broad range of biologically important molecules, the University of Kentucky College of Medicine has established a small molecule mass spectrometry facility. The addition of this facility to the analytical toolbox within the college will provide analytical capabilities that are essential for research that will ultimately improve the understanding, diagnosis and treatment of human disease. The facility is directed by Andrew J. Morris, and staffed by Manjula Sunkara and Sony Soman.

Notice Number: NOT-OD-13-126

Release Date: October 1, 2013

Issued by
National Institutes of Health (NIH)

Purpose